Skip to Main Content

An official website of the United States government

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Name Principal Investigator Institution Study Date Approved Project ID
Discrimination between Risk Profiles for Esophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma using Metabolomic Analysis Linda Liao NCI, DCEG, OEEB PLCO Nov 14, 2011 2011-0166
Disparities in Prostate Cancer Screening Behavior Between Blacks and Whites Wayne Lawrence Jiann-Ping Hsu College of Public Health PLCO Jan 9, 2015 PLCO-125
Disparity in time to treatment of cancer from after diagnosis between African American and White population and mortality outcomes Gurudatta Naik University of Alabama at Birmingham PLCO Oct 12, 2017 PLCO-312
Dissecting the risk of MGUS/MM in high-risk participants in the PLCO study Irene Ghobrial Dana-Farber Cancer Institute PLCO Oct 6, 2022 2021-1015
Distributed Automated Tuberculosis and Cancer Diagnosis Jochen Nessel Rai and Rohl Technologies, Inc. PLCO Feb 22, 2017 PLCO-256
Distribution of NLST imaging and limited clinical data through NCI public image repositories Keyvan Farahani National Cancer Institute NLST Apr 12, 2021 NLST-780
Diurnal pattern of physical activity and adherence to physical activity Tongyu Ma Franklin Pierce University IDATA Oct 3, 2022 IDATA-57
DNA Extraction Method, Biological Specimen, and DNA Yield for Genetic Studies in PLCO Leah Mechanic Westat PLCO Oct 9, 2008 2008-0042
DNA methylation and breast cancer risk Jirong Long Vanderbilt University Medical Center PLCO Sep 1, 2020 PLCO-663
DNA Methylation Markers and Prostate Cancer Risk Sonja Berndt NCI, DCEG, OEEB PLCO Dec 15, 2009 2009-0564
Does compliance with screening exams and forms completion differ by smoking status in PLCO? Pamela Marcus NCI, DCP, BRG PLCO Oct 22, 2010 2010-0158
Does Exclusion of Extreme Reporters of Energy Intake Make Results Less Biased in Nutrition Studies? Keisuke Ejima Indiana University IDATA Oct 31, 2017 IDATA-17
Do repeat normal lung screens lower model estimated baseline estimates of lung cancer risk? Martin Tammemagi Brock University NLST Jul 22, 2013 NLST-25
Downstream testing and interventions in the NLST Vinay Prasad NCI NLST Nov 7, 2014 NLST-95
DRE and LUTS Jonathan Shoag NA PLCO Nov 6, 2015 PLCO-177
DRE and prostate cancer detection in the PLCO cancer screening trial Jonathan Shoag NA PLCO Aug 24, 2015 PLCO-150
Drinking and pre-diagnosed BMI trajectories and their impact on the mortality of upper-gastrointestinal cancers in the PLCO population. Jianjun Li Sun Yat-Sen University Caner Center PLCO Nov 13, 2019 PLCO-546
Dynamic evolution and subtype qualitative analysis of early lung nodule from longitudinal CT images based on deep model Changmiao Wang Shenzhen Research Institute of Big Data NLST Mar 22, 2022 NLST-897
Dynamic Risk Prediction of Prostate Cancer Development Using Longitudinal Biomarkers of PSA Ming Wang The Pennsylvania State University PLCO Apr 20, 2021 PLCO-775
Dysanapsis and lung cancer Benjamin Smith The Trustees of Columbia University in the City of New York NLST Mar 10, 2021 NLST-768